NasdaqGM - Nasdaq Real Time Price • USD
Personalis, Inc. (PSNL)
At close: May 17 at 4:00 PM EDT
Pre-Market: 9:10 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.37 | -0.39 | -1.42 | -1.36 |
| Low Estimate | -0.4 | -0.43 | -1.55 | -1.65 |
| High Estimate | -0.32 | -0.29 | -1.13 | -0.76 |
| Year Ago EPS | -0.5 | -0.6 | -2.25 | -1.42 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | 19.26M | 18.68M | 76.97M | 84.79M |
| Low Estimate | 17.1M | 18.1M | 76.5M | 79.5M |
| High Estimate | 20.11M | 19.52M | 77.32M | 93.55M |
| Year Ago Sales | 16.49M | 18.25M | 73.48M | 76.97M |
| Sales Growth (year/est) | 16.80% | 2.40% | 4.70% | 10.20% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.53 | -0.53 | -0.5 | -0.41 |
| EPS Actual | -0.5 | -0.6 | -0.54 | -0.26 |
| Difference | 0.03 | -0.07 | -0.04 | 0.15 |
| Surprise % | 5.70% | -13.20% | -8.00% | 36.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.37 | -0.39 | -1.42 | -1.36 |
| 7 Days Ago | -0.38 | -0.39 | -1.49 | -1.36 |
| 30 Days Ago | -0.39 | -0.39 | -1.58 | -1.35 |
| 60 Days Ago | -0.39 | -0.39 | -1.58 | -1.35 |
| 90 Days Ago | -0.44 | -0.41 | -1.72 | -1.32 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 4 | 2 | 5 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PSNL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 26.00% | -- | -- | 8.00% |
| Next Qtr. | 35.00% | -- | -- | 12.40% |
| Current Year | 36.90% | -- | -- | 5.60% |
| Next Year | 4.20% | -- | -- | 12.60% |
| Next 5 Years (per annum) | -13.70% | -- | -- | 11.14% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 5/9/2024 |
| Initiated | Lake Street: Buy | 4/30/2024 |
| Reiterates | Needham: Buy to Buy | 4/11/2024 |
| Maintains | Needham: Buy to Buy | 2/29/2024 |
| Reiterates | Needham: Buy to Buy | 1/5/2024 |
| Maintains | Needham: Buy to Buy | 11/8/2023 |
Related Tickers
CDNA CareDx, Inc
15.50
+4.87%
VCYT Veracyte, Inc.
22.88
-2.22%
BDSX Biodesix, Inc.
1.5750
+0.96%
TWST Twist Bioscience Corporation
47.01
+1.10%
CSTL Castle Biosciences, Inc.
24.24
+0.08%
LAB Standard BioTools Inc.
2.5700
+2.80%
BNR Burning Rock Biotech Limited
8.30
+3.23%
ISPC iSpecimen Inc.
0.2410
-4.06%
GH Guardant Health, Inc.
25.36
-3.35%
ACRS Aclaris Therapeutics, Inc.
1.1900
+0.85%